{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T11:52:26Z","timestamp":1765885946267,"version":"build-2065373602"},"reference-count":70,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","maturitas.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Maturitas"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1016\/j.maturitas.2014.03.002","type":"journal-article","created":{"date-parts":[[2014,3,10]],"date-time":"2014-03-10T08:01:16Z","timestamp":1394438476000},"page":"131-137","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["EMAS position statement: The management of postmenopausal women with vertebral osteoporotic fracture"],"prefix":"10.1016","volume":"78","author":[{"given":"Ioannis K.","family":"Triantafyllopoulos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kalliopi","family":"Lambropoulou-Adamidou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cleopatra C.","family":"Nacopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikolaos A.","family":"Papaioannou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iuliana","family":"Ceausu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Herman","family":"Depypere","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. Tamer","family":"Erel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faustino R.","family":"P\u00e9rez-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karin","family":"Schenck-Gustafsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yvonne T.","family":"van der Schouw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tommaso","family":"Simoncini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florence","family":"Tremollieres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margaret","family":"Rees","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene","family":"Lambrinoudaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.maturitas.2014.03.002_bib0005","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s11657-011-0060-1","article-title":"Osteoporosis: burden health care provision and opportunities in the EU","volume":"6","author":"Strom","year":"2011","journal-title":"Arch Osteoporos"},{"key":"10.1016\/j.maturitas.2014.03.002_bib0010","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/s11657-013-0136-1","article-title":"Osteoporosis in the European Union: medical management, epidemiology and economic burden. A report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA)","volume":"8","author":"Hernlund","year":"2013","journal-title":"Arch Osteoporos"},{"key":"10.1016\/j.maturitas.2014.03.002_bib0015","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1056\/NEJMcp1009697","article-title":"Clinical practice. Vertebral fractures","volume":"364","author":"Ensrud","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.maturitas.2014.03.002_bib0020","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1359\/jbmr.090511","article-title":"FRAX and risk of vertebral fractures: the fracture intervention trial","volume":"24","author":"Donaldson","year":"2009","journal-title":"J Bone Min Res"},{"key":"10.1016\/j.maturitas.2014.03.002_bib0025","first-page":"205","article-title":"Vertebral compression fractures: a review of current management and multimodal therapy","volume":"6","author":"Wong","year":"2013","journal-title":"J Multidiscip Healthcare"},{"key":"10.1016\/j.maturitas.2014.03.002_bib0030","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s00198-006-0304-x","article-title":"The vertebral fracture cascade in osteoporosis: a review of aetiopathogenesis","volume":"18","author":"Briggs","year":"2007","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.maturitas.2014.03.002_bib0035","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1001\/jama.298.23.2761","article-title":"Long-term risk of incident vertebral fractures","volume":"298","author":"Cauley","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.maturitas.2014.03.002_bib0040","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1002\/jbmr.2028","article-title":"Prevalent vertebral fractures on chest CT: higher risk for future hip fracture","volume":"29","author":"Buckens","year":"2014","journal-title":"J Bone Min Res"},{"key":"10.1016\/j.maturitas.2014.03.002_bib0045","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1007\/s00198-011-1713-z","article-title":"Interpretation and use of FRAX in clinical practice","volume":"22","author":"Kanis","year":"2011","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.maturitas.2014.03.002_bib0050","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.maturitas.2013.05.013","article-title":"Diagnosis and management of osteoporosis in postmenopausal women and older men in the UK: National Osteoporosis Guideline Group (NOGG) update 2013","volume":"75","author":"Compston","year":"2013","journal-title":"Maturitas"},{"key":"10.1016\/j.maturitas.2014.03.002_bib0055","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s00198-012-2240-2","article-title":"The International Costs and Utilities Related to Osteoporotic Fractures Study (ICUROS)\u2014quality of life during the first 4 months after fracture","volume":"24","author":"Borgstrom","year":"2013","journal-title":"Osteoporosis Int"},{"key":"10.1016\/j.maturitas.2014.03.002_bib0060","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/j.jvir.2010.05.018","article-title":"Clinical course of pain in acute osteoporotic vertebral compression fractures","volume":"21","author":"Klazen","year":"2010","journal-title":"J Vasc Interv Radiol"},{"issue":"February (5)","key":"10.1016\/j.maturitas.2014.03.002_bib0065","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1001\/jama.2009.50","article-title":"Mortality risk associated with low-trauma osteoporotic fracture and subsequent fracture in men and women","volume":"301","author":"Bliuc","year":"2009","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.maturitas.2014.03.002_bib0070","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1007\/s00586-011-1852-0","article-title":"Vertebral fracture and cause-specific mortality: prospective population study of 3,210 men and 3,730 women with 30 years of follow-up","volume":"20","author":"Puisto","year":"2011","journal-title":"Eur Spine J"},{"key":"10.1016\/j.maturitas.2014.03.002_bib0075","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1148\/radiol.12110462","article-title":"Osteoporosis imaging: state of the art and advanced imaging","volume":"263","author":"Link","year":"2012","journal-title":"Radiology"},{"key":"10.1016\/j.maturitas.2014.03.002_bib0080","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1002\/jbmr.5650080915","article-title":"Vertebral fracture assessment using a semiquantitative technique","volume":"8","author":"Genant","year":"1993","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.maturitas.2014.03.002_bib0085","unstructured":"NICE pathway: osteoporosis overview. http:\/\/pathways.nice.org.uk\/pathways\/osteoporosis [accessed 12.02.14]."},{"issue":"October","key":"10.1016\/j.maturitas.2014.03.002_bib0090","article-title":"Use of a performance algorithm improves utilization of vertebral fracture assessment in clinical practice","author":"Schousboe","year":"2013","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.maturitas.2014.03.002_bib0095","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1007\/s00330-013-2792-3","article-title":"MRI for response assessment in metastatic bone disease","volume":"23","author":"Lecouvet","year":"2013","journal-title":"Eur Radiol"},{"key":"10.1016\/j.maturitas.2014.03.002_bib0100","doi-asserted-by":"crossref","first-page":"E80","DOI":"10.1097\/BSD.0b013e318261f438","article-title":"Usefulness of MRI in determining the appropriate level of cement augmentation for acute osteoporotic vertebral compression fractures","volume":"26","author":"Park","year":"2013","journal-title":"J Spinal Disord Tech"},{"key":"10.1016\/j.maturitas.2014.03.002_bib0105","unstructured":"NICE technology appraisal guidance TA279. Percutaneous vertebroplasty and percutaneous balloon kyphoplasty for treating osteoporotic vertebral compression fractures. Issued: April 2013 TA279. http:\/\/publications.nice.org.uk\/percutaneous-vertebroplasty-and-percutaneous-balloon-kyphoplasty-for-treating-osteoporotic-vertebral-ta279 [accessed 12.02.14]."},{"key":"10.1016\/j.maturitas.2014.03.002_bib0110","doi-asserted-by":"crossref","first-page":"E225","DOI":"10.36076\/ppj.2009\/12\/E264","article-title":"ASIPP. An algorithmic approach for clinical management of chronic spinal pain","volume":"12","author":"Manchikanti","year":"2009","journal-title":"Pain Physician"},{"issue":"2 Suppl.","key":"10.1016\/j.maturitas.2014.03.002_bib0115","first-page":"S5","article-title":"Opioids in the management of chronic non-cancer pain: an update of American Society of the Interventional Pain Physicians\u2019 (ASIPP) Guidelines","volume":"11","author":"Trescot","year":"2008","journal-title":"Pain Physician"},{"key":"10.1016\/j.maturitas.2014.03.002_bib0120","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1007\/s00198-004-1798-8","article-title":"Calcitonin for treating acute pain of osteoporotic vertebral compression fractures: a systematic review of randomized, controlled trials","volume":"16","author":"Knopp","year":"2005","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.maturitas.2014.03.002_bib0125","unstructured":"European Medicines Agency. Assessment report for calcitonin containing medicinal products EMA\/109665\/2013, Referral under Article 31 of Directive 2001\/83\/EC. http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Referrals_document\/Calcitonin_31\/WC500146172.pdf [accessed 12.02.04]."},{"key":"10.1016\/j.maturitas.2014.03.002_bib0130","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00198-011-1676-0","article-title":"Calcitonin for treating acute and chronic pain of recent and remote osteoporotic vertebral compression fractures: a systematic review and meta-analysis","volume":"23","author":"Knopp-Sihota","year":"2012","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.maturitas.2014.03.002_bib0135","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.pain.2013.09.016","article-title":"A pilot trial of intravenous pamidronate for chronic low back pain","volume":"155","author":"Pappagallo","year":"2014","journal-title":"Pain"},{"key":"10.1016\/j.maturitas.2014.03.002_bib0140","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ejphar.2012.11.031","article-title":"Analgesic effects of the non-nitrogen-containing bisphosphonates etidronate and clodronate, independent of anti-resorptive effects on bone","volume":"699","author":"Kim","year":"2013","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.maturitas.2014.03.002_bib0145","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1002\/jbmr.292","article-title":"Once-yearly zolendronic acid and days of disability, bed rest, and back pain: randomized, controlled HORIZON Pivotal Fracture Trial","volume":"26","author":"Cauley","year":"2011","journal-title":"J Bone Miner Res"},{"issue":"June","key":"10.1016\/j.maturitas.2014.03.002_bib0150","article-title":"Treatment persistence and changes in fracture risk, back pain, and quality of life amongst patients treated with teriparatide in routine clinical care in France: results from the European Forsteo Observational Study","author":"Rajzbaum","year":"2013","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.maturitas.2014.03.002_bib0155","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1007\/s00198-007-0530-x","article-title":"Back pain in osteoporotic vertebral fractures","volume":"19","author":"Francis","year":"2008","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.maturitas.2014.03.002_bib0160","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1007\/s00198-011-1639-5","article-title":"Balloon kyphoplasty and vertebroplasty in the management of vertebral compression fractures","volume":"22","author":"Boonen","year":"2011","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.maturitas.2014.03.002_bib0165","unstructured":"BMJ Best Practice. Osteoporotic spinal compression fractures. http:\/\/bestpractice.bmj.com\/best-practice\/monograph\/819\/highlights\/summary.html [accessed 17.02.14]."},{"key":"10.1016\/j.maturitas.2014.03.002_bib0170","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.maturitas.2012.02.010","article-title":"Vertebroplasty and kyphoplasty \u2013 a systematic review of cement augmentation techniques for osteoporotic vertebral compression fractures compared to standard medical therapy","volume":"72","author":"Robinson","year":"2012","journal-title":"Maturitas"},{"key":"10.1016\/j.maturitas.2014.03.002_bib0175","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1007\/s00586-012-2508-4","article-title":"Surgical patterns in osteoporotic vertebral compression fractures","volume":"22","author":"Patil","year":"2013","journal-title":"Eur Spine J"},{"key":"10.1016\/j.maturitas.2014.03.002_bib0180","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.ocl.2013.01.008","article-title":"Surgical stabilization of the spine in the osteoporotic patient","volume":"44","author":"Dodwad","year":"2013","journal-title":"Orthop Clin North Am"},{"key":"10.1016\/j.maturitas.2014.03.002_bib0185","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.maturitas.2012.10.019","article-title":"EMAS position statement: diet and health in midlife and beyond","volume":"74","author":"Lambrinoudaki","year":"2013","journal-title":"Maturitas"},{"key":"10.1016\/j.maturitas.2014.03.002_bib0190","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.maturitas.2011.11.002","article-title":"EMAS position statement: vitamin D and postmenopausal health","volume":"71","author":"P\u00e9rez-L\u00f3pez","year":"2012","journal-title":"Maturitas"},{"key":"10.1016\/j.maturitas.2014.03.002_bib0195","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.maturitas.2013.02.009","article-title":"Risk factors for falls among older adults: a review of the literature","volume":"75","author":"Ambrose","year":"2013","journal-title":"Maturitas"},{"issue":"1","key":"10.1016\/j.maturitas.2014.03.002_bib0200","first-page":"CD008618","article-title":"Exercise for improving outcomes after osteoporotic vertebral fracture","volume":"31","author":"Giangregorio","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.maturitas.2014.03.002_bib0205","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1136\/bmj.38753.375324.7C","article-title":"Effectiveness of hip protectors for preventing hip fractures in elderly people systematic review","volume":"332","author":"Parker","year":"2006","journal-title":"BMJ"},{"key":"10.1016\/j.maturitas.2014.03.002_bib0210","unstructured":"European Medicine Agency. Calcitonin. http:\/\/www.ema.europa.eu\/ema\/index.jsp?curl=pages\/medicines\/human\/referrals\/Calcitonin\/human_referral_000319.jsp&mid=WC0b01ac0580024e99 [accessed 12.02.14]."},{"key":"10.1016\/j.maturitas.2014.03.002_bib0215","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1177\/1759720X13483187","article-title":"A review on strontium ranelate long-term antifracture efficacy in the treatment of postmenopausal osteoporosis","volume":"5","author":"Cianferotti","year":"2013","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"10.1016\/j.maturitas.2014.03.002_bib0220","unstructured":"European Medicine Agency. Protelos and Osseor. European Medicines Agency recommends that Protelos\/Osseor remain available but with further restrictions. http:\/\/www.ema.europa.eu\/ema\/index.jsp?curl=pages\/medicines\/human\/referrals\/Protelos_and_Osseor\/human_referral_prac_000025.jsp&mid=WC0b01ac05805c516f [accessed 27.02.14]."},{"key":"10.1016\/j.maturitas.2014.03.002_bib0225","doi-asserted-by":"crossref","first-page":"691","DOI":"10.7326\/0003-4819-158-9-201305070-00603","article-title":"Vitamin D and calcium supplementation to prevent fractures in adults: U.S. Preventive Services Task Force Recommendation Statement","volume":"158","author":"Moyer","year":"2013","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.maturitas.2014.03.002_bib0230","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1185\/03007995.2013.766162","article-title":"Vitamin D supplementation in elderly or postmenopausal women: a 2013 update of the 2008 recommendations from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO)","volume":"29","author":"Rizzoli","year":"2013","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.maturitas.2014.03.002_bib0235","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.maturitas.2013.10.003","article-title":"Calcium risk-benefit updated\u2014new WHI analyses","volume":"77","author":"Reid","year":"2014","journal-title":"Maturitas"},{"key":"10.1016\/j.maturitas.2014.03.002_bib0240","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1007\/s00198-012-1958-1","article-title":"A framework for the development of guidelines for the management of glucocorticoids-induced osteoporosis","volume":"23","author":"Lekamwasam","year":"2012","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.maturitas.2014.03.002_bib0245","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s00774-008-0868-y","article-title":"Systematic review of the benefits and harms of calcitriol and alfacalcidol for fractures and falls","volume":"26","author":"O\u2019Donnell","year":"2008","journal-title":"J Bone Miner Metab"},{"year":"2013","series-title":"Vitamin D and Bone Health: A Practical Clinical Guideline for Patient Management","author":"National Osteoporosis Society","key":"10.1016\/j.maturitas.2014.03.002_bib0250"},{"key":"10.1016\/j.maturitas.2014.03.002_bib0255","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial","volume":"288","author":"Rossouw","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.maturitas.2014.03.002_bib0260","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1001\/jama.291.14.1701","article-title":"Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial","volume":"291","author":"Anderson","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.maturitas.2014.03.002_bib0265","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0140-6736(03)14596-5","article-title":"Breast cancer and hormone-replacement therapy in the Million Women Study","volume":"362","author":"Beral","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.maturitas.2014.03.002_bib0270","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.maturitas.2013.02.001","article-title":"Global consensus statement on menopausal hormone therapy","volume":"74","author":"De Villiers","year":"2013","journal-title":"Maturitas"},{"key":"10.1016\/j.maturitas.2014.03.002_bib0275","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1056\/NEJMoa0800743","article-title":"The effects of tibolone in older postmenopausal women","volume":"359","author":"Cummings","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.maturitas.2014.03.002_bib0280","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.maturitas.2011.11.018","article-title":"An update on selective estrogen receptor modulators for the prevention and treatment of osteoporosis","volume":"71","author":"Komm","year":"2012","journal-title":"Maturitas"},{"key":"10.1016\/j.maturitas.2014.03.002_bib0285","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.maturitas.2011.11.010","article-title":"EMAS clinical guide: selective estrogen receptor modulators for postmenopausal osteoporosis","volume":"71","author":"Palacios","year":"2012","journal-title":"Maturitas"},{"key":"10.1016\/j.maturitas.2014.03.002_bib0290","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s00198-005-2030-1","article-title":"Anti-vertebral fracture efficacy of raloxifene: a meta-analysis","volume":"17","author":"Seeman","year":"2006","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.maturitas.2014.03.002_bib0295","doi-asserted-by":"crossref","first-page":"698","DOI":"10.7326\/0003-4819-159-10-201311190-00718","article-title":"Medications for risk reduction of primary breast cancer in women: U.S. Preventive Services Task Force Recommendation Statement","volume":"159","author":"Moyer","year":"2013","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.maturitas.2014.03.002_bib0300","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s00198-011-1691-1","article-title":"Sustained efficacy and safety of bazedoxifene in preventing fractures in postmenopausal women with osteoporosis: results of a 5-year, randomized, placebo-controlled study","volume":"23","author":"Silverman","year":"2012","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.maturitas.2014.03.002_bib0305","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1210\/jc.2012-1027","article-title":"Benefits and risks of bisphosphonate therapy for osteoporosis","volume":"97","author":"Khosla","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.maturitas.2014.03.002_bib0310","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1056\/NEJMoa0809493","article-title":"Denosumab for prevention of fractures in postmenopausal women with osteoporosis","volume":"361","author":"Cummings","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.maturitas.2014.03.002_bib0315","doi-asserted-by":"crossref","first-page":"4483","DOI":"10.1210\/jc.2013-1597","article-title":"The effect of three or six years of denosumab exposure in women with postmenopausal osteoporosis: results from the FREEDOM extension","volume":"98","author":"Bone","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.maturitas.2014.03.002_bib0320","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1002\/jbmr.1606","article-title":"Denosumab reduces the risk of osteoporotic fractures in postmenopausal women, particularly in those with moderate to high fracture risk as assessed with FRAX","volume":"27","author":"McCloskey","year":"2012","journal-title":"J Bone Min Res"},{"key":"10.1016\/j.maturitas.2014.03.002_bib0325","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1056\/NEJM200105103441904","article-title":"Effect of parathyroid hormone (1\u201334) on fractures and bone mineral density in postmenopausal women with osteoporosis","volume":"344","author":"Neer","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.maturitas.2014.03.002_bib0330","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.ecl.2012.05.002","article-title":"Anabolic therapies for osteoporosis","volume":"41","author":"Uihlein","year":"2012","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.maturitas.2014.03.002_bib0335","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.bone.2013.11.011","article-title":"Effects of teriparatide on cortical histomorphometric variables in postmenopausal women with or without prior alendronate treatment","volume":"59","author":"Ma","year":"2014","journal-title":"Bone"},{"key":"10.1016\/j.maturitas.2014.03.002_bib0340","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1359\/jbmr.2003.18.1.18","article-title":"The skeletal response to teriparatide is largely independent of age, initial bone mineral density, and prevalent vertebral fractures in postmenopausal women with osteoporosis","volume":"18","author":"Marcus","year":"2003","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.maturitas.2014.03.002_bib0345","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.jocd.2013.08.004","article-title":"Executive summary of the 2013 International Society for Clinical Densitometry Position Development Conference on bone densitometry","volume":"16","author":"Schousboe","year":"2013","journal-title":"J Clin Densitom"},{"key":"10.1016\/j.maturitas.2014.03.002_bib0350","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/nrrheum.2012.86","article-title":"Bone turnover markers: use in osteoporosis","volume":"8","author":"Naylor","year":"2012","journal-title":"Nat Rev Rheumatol"}],"container-title":["Maturitas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S037851221400067X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S037851221400067X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T08:59:13Z","timestamp":1759913953000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S037851221400067X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":70,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["S037851221400067X"],"URL":"https:\/\/doi.org\/10.1016\/j.maturitas.2014.03.002","relation":{},"ISSN":["0378-5122"],"issn-type":[{"type":"print","value":"0378-5122"}],"subject":[],"published":{"date-parts":[[2014,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"EMAS position statement: The management of postmenopausal women with vertebral osteoporotic fracture","name":"articletitle","label":"Article Title"},{"value":"Maturitas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.maturitas.2014.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Published by Elsevier Ireland Ltd.","name":"copyright","label":"Copyright"}]}}